Novartis Investigative Site

Bad Bramstedt 24576

0 studies enrolling now · 1 studies all time

What they study most

Systemic Juvenile Idiopathic Arthritis

Studies at this site

• An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. — Completed